These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3510801)

  • 1. Evaluation of glycerol as an osmotic agent for continuous ambulatory peritoneal dialysis in end-stage renal failure.
    Heaton A; Ward MK; Johnston DG; Alberti KG; Kerr DN
    Clin Sci (Lond); 1986 Jan; 70(1):23-9. PubMed ID: 3510801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term studies on the use of glycerol as an osmotic agent in continuous ambulatory peritoneal dialysis (CAPD).
    Heaton A; Ward MK; Johnston DG; Nicholson DV; Alberti KG; Kerr DN
    Clin Sci (Lond); 1984 Jul; 67(1):121-30. PubMed ID: 6734073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical analysis of osmotic agents in peritoneal dialysis. What size is an ideal osmotic agent?
    Rippe B; Zakaria el-R ; Carlsson O
    Perit Dial Int; 1996; 16 Suppl 1():S97-103. PubMed ID: 8728172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial.
    Bonomini M; Di Liberato L; Del Rosso G; Stingone A; Marinangeli G; Consoli A; Bertoli S; De Vecchi A; Bosi E; Russo R; Corciulo R; Gesualdo L; Giorgino F; Cerasoli P; Di Castelnuovo A; Monaco MP; Shockley T; Rossi C; Arduini A
    Am J Kidney Dis; 2013 Nov; 62(5):929-38. PubMed ID: 23725973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino-acid-based continuous ambulatory peritoneal dialysis (CAPD) fluid over twelve weeks: effects on carbohydrate and lipid metabolism.
    Dibble JB; Young GA; Hobson SM; Brownjohn AM
    Perit Dial Int; 1990; 10(1):71-7. PubMed ID: 2085587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial with a 0.6% amino acid/ 1.4% glycerol peritoneal dialysis solution.
    Van Biesen W; Boer W; De Greve B; Dequidt C; Vijt D; Faict D; Lameire N
    Perit Dial Int; 2004; 24(3):222-30. PubMed ID: 15185770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1% amino acid peritoneal dialysate: single-cycle study in diabetic patients with end-stage renal disease.
    Arfeen S; Goodship TH; Kirkwood A; Channon S; Ward MK
    Am J Kidney Dis; 1994 Jan; 23(1):86-90. PubMed ID: 8285202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease.
    Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
    Canbakan M; Sahin GM
    Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of an amino acid-based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass.
    Brulez HF; van Guldener C; Donker AJ; ter Wee PM
    Nephrol Dial Transplant; 1999 Jan; 14(1):154-9. PubMed ID: 10052496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate and lipid metabolism during continuous ambulatory peritoneal dialysis (CAPD): the effect of a single dialysis cycle.
    Heaton A; Johnston DG; Burrin JM; Orskov H; Ward MK; Alberti KG; Kerr DN
    Clin Sci (Lond); 1983 Nov; 65(5):539-45. PubMed ID: 6352157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients.
    Gürsu EM; Ozdemir A; Yalinbas B; Gürsu RU; Canbakan M; Güven B; Atasoyu EM; Keskin AT; Elçi A; Baru Y
    Clin Nephrol; 2006 Oct; 66(4):263-8. PubMed ID: 17063993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
    Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
    J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of peritoneal dialysis with glycerol and glucose as osmotic agents.
    Lindholm B; Werynski A; Bergström J
    ASAIO Trans; 1987; 33(1):19-27. PubMed ID: 3828158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alternative osmotic agents on peritoneal transport.
    Waniewski J; Werynski A; Heimbürger O; Park MS; Lindholm B
    Blood Purif; 1993; 11(4):248-64. PubMed ID: 8297566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-month overnight administration of intraperitoneal amino acids does not improve lean mass.
    Maurer O; Saxenhofer H; Jaeger P; Casez JP; Descoeudres C; Horber FF
    Clin Nephrol; 1996 May; 45(5):303-9. PubMed ID: 8738661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
    Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.